p53 codon 72 arg/pro polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix

International Journal of Cancer

Volumn 83, Issue 1, 1999, Pages 66-69

  Giannoudis, Athina ^a   Graham, David A ^a   Southern, Shirley A ^a   Herrington, C Simon ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; DNA DETERMINATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS TYPING; WART VIRUS;

ARGININE; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROLINE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0032856556     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990924)83:1<66::AID-IJC13>3.0.CO;2-K     Document Type: Article

References (21)

1. CUZICK, J., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Screening for cervical cancer. Lancet, 351, 1439-1440 (1998).
2. DARNTON, S.J., Demystified p53. J. clin. Pathol. mol. Pathol., 51, 248-253 (1998).
3. DE LA CALLE-MARTIN, O., FABREGAT, V., ROMERO, M., SOLER, J., VIVES, J. and YAGUE, J., AccII polymorphism of the p53 gene. Nucl. Acids Res., 18, 4963 (1990).
4. HAYES, V.M., HOFSTRA, R.M.W., BUYS, C.H.C.M., HOLLEMA, H. and VAN DER ZEE, A.G.J., Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet, 352, 1756 (1998).
5. HELLAND, A., LANGEROD, A., JOHNSEN, H., OLSEN, A.O., SKOVLUND, E. and BORRESEN-DALE, A.-L., p53 polymorphism and risk of cervical cancer. Nature (Lond.), 396, 530-531 (1998).
6. HILDESHEIM, A. AND 14 OTHERS, p53 polymorphism and risk of cervical cancer. Nature (Lond.), 396, 531-532 (1998).
7. HO, G.Y.F., BURK, R.D., KLEIN, S., KADISH, A.S., CHANG, C.J., PALAN, P., BASU, J., TACHEZY, R., LEWIS, R. AND ROMNEY, S., Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. nat. Cancer Inst., 87, 1365-1371 (1995).
8. JACOBS, M.V., DE RODA HUSMAN, A.M., VAN DEN BRULE, A.J.C., SNIJDERS, P.J.F., MEIJER, C.J.L.M. and WALBOOMERS, J.M.M., Group-specific differentiation between high and low risk human papillomavirus genotypes by general primer mediated PCR and two cocktails of oligonucleotide probes. J. clin. Pathol., 33, 901-905 (1995).
9. JOSEFSSON, A.M., MAGNUSSON, P.K.E., YLITALO, N., QUARFORTH-TUBBIN, P., PONTEN, J., ADAMI, H.O. and GYLLENSTEN, U.B., p53 polymorphism and risk of cervical cancer. Nature (Lond.), 396, 531 (1998).
10. LANHAM, S., CAMPBELL, I., WATT, P. and GORNALL, R., p53 polymorphism and risk of cervical cancer. Lancet, 352, 1631 (1998).
11. LORINCZ, A.T., REID, R., JENSON, A.B., GREENBERG, M.D., LANCASTER, W. and KURMAN, R.J., Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol., 79, 328-337 (1992).
12. MINAGUCHI, T., KANAMORI, Y., MATSUSHIMA, M., YOSHIKAWA, H., TAKENAMI, Y. and NAKAMURA, Y., No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res., 58, 4585-4586 (1998).
13. MULLOKANDOV, M.R., Kholodilov, N.G., Atkin, N.B., Burk, R.D., Johnson, A.B. and Klinger, H.P., Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res., 56, 197-205 (1996).
14. MURATA, M., TAGAWA, M., KIMURA, M., KIMURA, H., WATANABE, S. and SAISHO, H., Analysis of a germ line polymorphism in lung cancer patients; discrete results with smoking history. Carcinogenesis, 17, 261-264 (1996).
15. REMMINK, A.J., WALBOOMERS, J.M.M., HELMERHORST, T.J.M., VOORHORST, F.J., ROZENDAAL, L., RISSE, E.K., MEIJER, C.J.L.M. and KENEMANS, P., The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease - natural history up to 36 months. Int. J. Cancer, 61, 306-311 (1995).
16. ROSENTHAL, A.N., RYAN, A., AL-JEHANI, R.M., STOREY, A., HARWOOD, C.A. and JACOBS, I.J., p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet, 352, 871-872 (1998).
17. SJALENDER, A., BIRGANDER, R., ATHLIN, L., STENLING, R., RUTEGARD, J., BECKMAN, L. and BECKMAN, G., p53 germ line haplotypes associated with increased risk for colorectal cancer. Carcinogenesis, 16, 1461-1464 (1995).
18. SOUTHERN, S.A., EVANS, M.F. and HERRINGTON, C.S., Basal cell tetrasomy occurs in low grade cervical squamous intra-epithelial lesion infected with high risk human papillomaviruses. Cancer Res., 57, 4210-4213 (1997).
19. STOPPLER, M.C., CHING, K., STOPPLER, H., CLANCY, K., SCHLEGEL, R. and ICENOGLE, J., Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol., 70, 6987-6993 (1996).
20. STOREY, A., THOMAS, M., KALITA, A., HARWOOD, C., GARDIOL, D., MANTOVANI, F., BREUER, J., LEIGH, I.M., MATLASHEWSKI, G. and BANKS, L., Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (Lond.), 393, 229-234 (1998).
21. ZEHBE, I., VOGLINO, G., DELIUS, H., WILANDER, E. AND TOMMASINO, M., Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphism. Lancet, 352, 1441-1442 (1998).